Mark A. Socinski, MD

Mark A. Socinski, MD, is the director of the Lung Cancer Section, Division of Hematology/Oncology, co-director of the UPMC Lung Cancer Center of Excellence, and co-director of the Lung and Thoracic Malignancies Program at UPMC Cancer Pavilion in Pittsburgh, Pennsylvania.

Most Recent Articles by Mark A. Socinski, MD

Improving Survival in Advanced NSCLC: Multiple Lines of Chemotherapy Make a Difference

Improving Survival in Advanced NSCLC: Multiple Lines of Chemotherapy Make a Difference

By

Oncologists who care for non-small cell lung cancer (NSCLC) patients need to develop management strategies.

Q&A with Mark Socinski, MD, on the POINTBREAK Trial of Maintenance Therapy for NSCLC

Q&A with Mark Socinski, MD, on the POINTBREAK Trial of Maintenance Therapy for NSCLC

By

Editorial Advisory Board member Dr. Socinski discusses the key clinical insights brought to light by the POINTBREAK trial, presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.

Crizotinib Treatment in ROS1-positive NSCLC Patients: A Case Study

Crizotinib Treatment in ROS1-positive NSCLC Patients: A Case Study

By

Although prevalence of cytogenetic abnormality in tumor biopsy is low, finding one or more abnormalities can expand the patient's treatment options.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters